Transdermal administration of nicotine
- PMID: 6734425
- DOI: 10.1016/0376-8716(84)90061-9
Transdermal administration of nicotine
Abstract
The physiological response to nicotine topically applied to the skin was measured in an adult male volunteer. Nicotine base (9 mg) was applied in a 30% aqueous solution to intact skin on the underside of the forearm. Salivary nicotine, heart rate and blood pressure were monitored for 12 h after application of the nicotine. Within 30 min a significant level of nicotine was detected in the saliva (50 ng/ml), pulse had risen by 15 beats/min and systolic blood pressure had risen 10 mmHg. Nicotine levels remained elevated for 2 h and were comparable to levels of nicotine produced by cigarette smoking. Because previous research has shown nicotine to suppress smoking behavior, it may be fruitful to examine transdermal administration of nicotine as a smoking reduction and cessation aid.
Similar articles
-
Transdermal nicotine reduces cigarette craving and nicotine preference.Clin Pharmacol Ther. 1985 Oct;38(4):450-6. doi: 10.1038/clpt.1985.203. Clin Pharmacol Ther. 1985. PMID: 4042528 Clinical Trial.
-
Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: a double-blind study in healthy smokers.Cardiovasc Drugs Ther. 1996 May;10(2):179-84. doi: 10.1007/BF00823596. Cardiovasc Drugs Ther. 1996. PMID: 8842510 Clinical Trial.
-
Nicotine replacement in smoking cessation. Absorption of nicotine vapor from smoke-free cigarettes.JAMA. 1987 Jun 19;257(23):3262-5. JAMA. 1987. PMID: 3586251
-
Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.Arch Fam Med. 1993 Apr;2(4):417-23. doi: 10.1001/archfami.2.4.417. Arch Fam Med. 1993. PMID: 8130921 Review.
-
Efficiency of multimodal smoking cessation therapy combining transdermal nicotine substitution with behavioral therapy.Methods Find Exp Clin Pharmacol. 1989 Mar;11(3):215-8. Methods Find Exp Clin Pharmacol. 1989. PMID: 2657277 Review.
Cited by
-
Nicotinic systems and cognitive function.Psychopharmacology (Berl). 1992;108(4):417-31. doi: 10.1007/BF02247415. Psychopharmacology (Berl). 1992. PMID: 1357713
-
The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.Clin Pharmacokinet. 2001;40(9):661-84. doi: 10.2165/00003088-200140090-00003. Clin Pharmacokinet. 2001. PMID: 11605715 Review.
-
The delivery and uptake of nicotine from an aerosol rod.Am J Public Health. 1986 Nov;76(11):1343-4. doi: 10.2105/ajph.76.11.1343. Am J Public Health. 1986. PMID: 3766836 Free PMC article.
-
Ultrasound-enhanced transdermal delivery: recent advances and future challenges.Ther Deliv. 2014 Jul;5(7):843-57. doi: 10.4155/tde.14.32. Ther Deliv. 2014. PMID: 25287389 Free PMC article. Review.
-
Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.Pharm Res. 1991 Mar;8(3):385-8. doi: 10.1023/a:1015810019076. Pharm Res. 1991. PMID: 2052530
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources